These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36069490)

  • 1. Editorial Comment: Gadolinium-Based Contrast Agent and the Central Vein Sign.
    Rubinstein D
    AJR Am J Roentgenol; 2023 Jan; 220(1):125. PubMed ID: 36069490
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis: prevalence of the 'central vein' sign in white matter lesions on gadolinium-enhanced susceptibility-weighted images.
    Sparacia G; Agnello F; Iaia A; Banco A; Galia M; Midiri M
    Neuroradiol J; 2021 Oct; 34(5):470-475. PubMed ID: 33872085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment: Toward Meeting ACR-ASNR Guidelines for Reducing Gadolinium-Based Contrast Agent Dose in Brain MRI Examinations.
    Cousins JP
    AJR Am J Roentgenol; 2021 Nov; 217(5):1205. PubMed ID: 34570589
    [No Abstract]   [Full Text] [Related]  

  • 4. "Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
    Goischke HK
    Radiology; 2016 Oct; 281(1):323-4. PubMed ID: 27643774
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
    Gentili L; Capuano R; Gaetani L; Fiacca A; Bisecco A; d'Ambrosio A; Mancini A; Guercini G; Tedeschi G; Parnetti L; Gallo A; Di Filippo M
    J Neurol Sci; 2022 Nov; 442():120422. PubMed ID: 36162167
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Gadolinium-based Contrast Material Needed for MRI Follow-up of Multiple Sclerosis?
    Saindane AM
    Radiology; 2019 May; 291(2):436-437. PubMed ID: 30860449
    [No Abstract]   [Full Text] [Related]  

  • 8. Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
    Forslin Y; Martola J; Bergendal Å; Fredrikson S; Wiberg MK; Granberg T
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1265-1273. PubMed ID: 31248867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do you believe in Gad?
    Maghzi AH; Sicotte NL; Waubant E
    Mult Scler Relat Disord; 2020 Sep; 44():102299. PubMed ID: 32593143
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.
    Rovira À; Auger C
    AJR Am J Roentgenol; 2022 Jul; 219(1):26-27. PubMed ID: 34786958
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA
    Eur Radiol; 2016 Mar; 26(3):818-9. PubMed ID: 26391361
    [No Abstract]   [Full Text] [Related]  

  • 13. The usefulness of gadolinium-enhanced images on a follow-up magnetic resonance image in suspected multiple sclerosis.
    Moore FG; Levental M
    Can Assoc Radiol J; 2013 Nov; 64(4):358-62. PubMed ID: 23267520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
    Forslin Y; Shams S; Hashim F; Aspelin P; Bergendal G; Martola J; Fredrikson S; Kristoffersen-Wiberg M; Granberg T
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1311-1316. PubMed ID: 28495943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacological economic analysis of application of magnetic resonance contrast mediums containing gadolinium in case of multiple sclerosis].
    Shegay MM; Shimanovsky DN
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Mar; 29(2):343-346. PubMed ID: 33901380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
    Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
    Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging new lesions: enhancing our understanding of multiple sclerosis pathogenesis.
    Fisher E; Reich DS
    Neurology; 2013 Jul; 81(3):202-3. PubMed ID: 23761620
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Raynaud JS; Darmon-Kern E; Lancelot E; Laurent AC; Desché P
    Radiol Med; 2018 Jun; 123(6):432-433. PubMed ID: 29476438
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A
    Radiol Med; 2018 Jul; 123(7):535-537. PubMed ID: 29560604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.